慢性炎性脱髓鞘性多神经病变（chronic inflammatory demyelinating polyneuropathy, CIDP）是一种不常见的疾病，具有突发性症状，包括影响运动、感觉、语言 ...

Incidentally identified demyelinating pathology within the CNS has been extensively documented in neuropathological studies, and is increasingly being reported during MRI-based premortem ...

The discovery that IgG4 autoantibodies against node of Ranvier proteins are linked to distinct subsets of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) represents a key advance ...

Demyelinating Diseases. This article has multiple parts: First of Four Parts; Third of Four Parts; Fourth of Four Parts; Author: George A. Schumacher, M.D. Author Info & Affiliations.

Multiple sclerosis is a chronic, inflammatory, demyelinating disease of the central nervous system that most commonly affects women, with an onset typically between 20 and 40 years of age.

Optical coherence tomography is beneficial for measuring visual changes and the impact of comorbidities in MS, NMOSD, and ...

Background: Chronic inflammatory demyelinating polyradiculoneuropathy is a rare acquired immune-mediated progressive or relapsing disorder causing peripheral neuropathic disease of duration more ...

A study led by Cambridge researchers has shed light on how neural stem cell grafts could help restore myelin in the central nervous system. The findings suggest that neural stem cell-based therapies ...

Inflammatory demyelinating pseudotumor usually occurs in the brain and rarely occurs in the spinal cord. On imaging, inflammatory demyelinating pseudotumor appears very similar to intramedullary ...

DUBLIN--(BUSINESS WIRE)--The "Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H2 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.Chronic ...

Paraneoplastic Demyelinating Sensorimotor Neuropathy Delaying the Diagnosis of an Underlying Acute Lymphoblastic Leukemia in a Child. JOP 14 , 629-631 (2018). DOI: 10.1200/JOP.18.00200 ...

The MHLW approval is based on the ADHERE Study, the largest clinical trial to date studying CIDP. In the ADHERE study, 69% (221/322) of patients treated with VYVDURA, regardless of prior treatment ...